Also trades as: ALVO (NASDAQ) · $vol 5M
ALVOW NASDAQ
Alvotech
1W: -61.4%
1M: -43.3%
3M: -15.7%
YTD: -78.2%
1Y: -85.2%
3Y: -88.7%
$0.17
-0.03 (-14.96%)
Weekly Expected Move ±62.4%
$-0
$0
$0
$1
$1
Credit Risk of going bust: higher than 88% of companies Debt: 46.1% of company value Bonds: none of note held by US funds details ▾
If the stock fell to about $0.02 (down 90%), Alvotech would be worth roughly what it owes.
Total debt $1.45B against a stock market value of $1.69B.
Distance to default 1.86 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $685.8M (short-term plus half of long-term), stock volatility 81.2%; Altman Z'' -4.58. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Total debt $1.45B against a stock market value of $1.69B.
Distance to default 1.86 (Merton model): prices to 2026-10-27, balance sheet 2026-06-30, debt counted $685.8M (short-term plus half of long-term), stock volatility 81.2%; Altman Z'' -4.58. A ranking and a back-test, not a forecast.
US fund filings (SEC N-PORT) show under $25M of this company's bonds, so there is no bond page. Its debt may be bank loans or privately placed. How these are computed.
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$1.6B
52W Range0.1188-2.46
Volume1,120
Avg Volume3,793
Beta0.19
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOLisa Graver
Employees1,460
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
IPO Date2022-06-16
Websitealvotech.com
9, Rue de Bitbourg
Luxembourg, LU 1273
LU
Luxembourg, LU 1273
LU
354 422 4500
About Alvotech
Alvotech Holdings SA is an Icelandic enterprise that, operating via its subsidiary companies, undertakes the development and fabrication of biosimilar pharmaceuticals destined for international consumption.
Latest News
Recent Insider Trades
No insider trades found